AAO 2020 – Dry Eye Disease | Physician's Weekly
Advertisement

AAO 2020 – Dry Eye Disease

PhysQuiz Answers! AAO 2020 on Dry Eye

Thank you for taking our quiz! How did you do? 1) According to an AAO IRIS® Registry Analysis, the overall prevalence of dry eye disease (DED) was about 30% in patients 3 months prior cataract surgery, but only what percent of...

Conference Coverage of AAO 2020: Dry Eye – eBook

AAO 2020 eBook – Dry Eye Featuring Impact of Dry Eye Signs & Symptoms on Work Productivity Severe DED in Chronic GVHD: Assessing the Role of Serum Vitamin A Examining the Role of Microneuromas Markers in Neuropathic...

HBM9036 Nasal Spray for Dry Eye Disease

HBM9036 ophthalmic solution 0.25%,  also known as tanfanercept, a novel TNF-α inhibitor, is safe and effective for improving certain symptoms of dry eye disease, according to results of a phase 2 randomized, a double-blind...

Impact of Dry Eye Signs & Symptoms on Work Productivity

Dry eye disease (DED) is a highly prevalent syndrome that manifests with symptoms that include constant irritation, burning or stinging sensations, and feelings of grittiness in the eyes. “DED is a chronic pain syndrome often...

HBM9036 Nasal Spray for Dry Eye Disease

HBM9036 ophthalmic solution 0.25%,  also known as tanfanercept, a novel TNF-α inhibitor, is safe and effective for improving certain symptoms of dry eye disease, according to results of a phase 2 randomized, a double-blind...

Loading

Advertisement

For latest news and updates
Email-id is invalid